Skip to content

Glycaemic and Insulinaemic Responses After Consumption of FOS.

Postprandial Glycaemic and Insulinaemic Responses After Consumption of Dairy Desserts Containing Fructo-oligosaccharides in Adults.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02353403
Acronym
GLYCOFOS-cream
Enrollment
27
Registered
2015-02-02
Start date
2014-01-31
Completion date
2014-02-28
Last updated
2015-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glycaemia

Keywords

Fructo-oligosaccharides, Sugar-reduced foods, Postprandial glucose response

Brief summary

The study aims to evaluate the glycaemic and insulinaemic response of short-chain fructo-oligosaccharides (scFOS) used to replace sugars (e.g. dextrose) in foods.

Interventions

OTHERSugar

A 210g chocolate dairy dessert made with 35g of dextrose.

OTHERFOS

A 210g chocolate dairy dessert made with 24g of dextrose and 11.2g of FOS.

Sponsors

Syral
CollaboratorINDUSTRY
Institut Pasteur de Lille
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

* Body mass index (BMI) between 18.0 and 25.0 kg/m² (included) * Ready to keep the same volume of physical activity and the same dietary habits during the study and particularly 24 hours before each visit * Be used to have breakfast * Non-smoker for at least 3 months * For the female participant: not being pregnant or breastfeeding and using efficient birth control * Signed the consent form * Able to follow the instructions of the study * Health insured * Accepted to be included in the National Registry for biomedical research Volunteers (Fichier VRB, Volontaires Recherches Biomédicales).

Exclusion criteria

* Fasting blood glucose over 6.1 mmol/L (1.10 g/L) (or diabetes treated or not) * Fasting blood cholesterol over 6.35 mmol/L * Fasting blood triglycerides over 1.70 mmol/L (or history of insulinoma) * Fasting blood insulin under 20 mU/L * Fasting HbA1c under 7% * History of hypercholesterolemia, hypertension, diabetes or glucose intolerance treated or not * History of dietary allergies or coeliac disease * History of digestive system disease susceptible to modify digestion or absorption like Crohn's disease * Somatic or psychiatric disorders * Renal insufficiency (kidney failure) * SGOT or ALAT over 52.5 U/L * Smoker * Consuming more than 3 alcoholic beverage a day * Weight varied 3 kg the last 3 months

Design outcomes

Primary

MeasureTime frameDescription
Glycaemic response2 hours and 5 minutesBlood glucose kinetics with 7 points. Analysis of the Area under the curve of glucose.

Secondary

MeasureTime frameDescription
Insulinaemic response2 hours and 5 minutesBlood insulin kinetics with 7 points. Analysis of the Area under the curve of insulin.
Blood glucose peak (Cmax)One-time data (the highest one) within the 2hrs 5mins kinetics.Peak of blood glucose during kinetics.
Blood insulin peak (Cmax)One-time data (the highest one) within the 2hrs 5mins kinetics.Peak of blood insulin during kinetics.
Glucose Tmax : time to reach the peak of blood glucoseOne time within the 2hrs 5mins kinetics.
Insulin Tmax : time to reach the peak of blood insulinOne time within the 2hrs 5mins kinetics.

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026